An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial. [electronic resource]
Producer: 20160322Description: 630-8 p. digitalISSN:- 1029-2403
- Adaptor Proteins, Signal Transducing -- metabolism
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Cyclophosphamide -- therapeutic use
- Dexamethasone -- therapeutic use
- Doxorubicin -- therapeutic use
- Female
- Fusion Proteins, bcr-abl -- metabolism
- Humans
- Imatinib Mesylate -- therapeutic use
- Male
- Middle Aged
- Nuclear Proteins -- metabolism
- Philadelphia Chromosome -- drug effects
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Reverse Transcriptase Polymerase Chain Reaction
- Verapamil -- therapeutic use
- Vincristine -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.